MedTrace Logo

Trinity Elite in Lumbar Fusion

NCT02969616 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-08-11

No results posted yet for this study

Summary

This prospective, post-market, open label clinical study is designed to examine the lumbar fusion rate at 24 months post operative in subjects who have undergone a lumbar fusion surgery using Trinity Elite with or without local bone.

Conditions

  • Degenerative Disc Disease

Interventions

BIOLOGICAL

Trinity Elite

cell based allograft

Sponsors & Collaborators

  • Orthofix Inc.

    lead INDUSTRY

Principal Investigators

  • Alan Daniels, MD · Brown University

  • Daniel Park, MD · Beaumont Hospital

  • Fernando Techy, MD · ClinTech Center for Spine Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2022-02-28
Completion
2022-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969616 on ClinicalTrials.gov